Philip Osbak/LinkedIn
Nov 21, 2026, 15:50
Philip Osbak: Co-Editing a New Research Topic in Frontiers in Cardiovascular Medicine
Philip Osbak, MD, PHD, Bispebjerg AND Frederiksberg Hospital, shared a post on LinkedIn:
“I am co-editing a research topic in Frontiers in Cardiovascular Medicine, Heart Failure and Transplantation:
‘Individualized Anticoagulation and Risk Stratification in Atrial Fibrillation-Related Thromboembolism’
Please get in touch with me if you consider submitting a manuscript on this important topic.
Deadline for submissions is 23 May 2027.”

Stay updated with Hemostasis Today.
-
Nov 21, 2026, 15:30Amin Marashi: How Does the Microbiome Trigger the Immune System to Suddenly Turn Against the Body’s Own Blood-Clotting Regulators?
-
Nov 21, 2026, 15:26Christina P.: Exploring Joint Involvement and Musculoskeletal Symptoms in Antiphospholipid Syndrome
-
Nov 21, 2026, 14:4410 Posts Not to Miss This Week
-
Nov 21, 2026, 14:21Two Emerging Mechanisms Linking Sickle Cell Disease to Thrombosis
-
Nov 21, 2026, 13:06Christine Faressa: Precision PRP and Platelet Biology in Musculoskeletal Care
-
Nov 21, 2026, 13:04Eyad Jamileh: Atrial Fibrillation – Bridging the Global Gaps in Diagnosis and Stroke Prevention
-
Nov 21, 2026, 12:49Thibault Veyron: Optimizing Bivalirudin Treatment in HIT
-
Nov 21, 2026, 12:44Paulus Kirchhof: Left Atrial Appendage Occlusion vs DOACs
-
Nov 21, 2026, 12:19Jiyeon Kim: Human Platelet Lysate – Advancing Cell Therapy and Space Research